CHARLTON ARIA ACQUISITI-CL A (CHAR) Fundamental Analysis & Valuation

NASDAQ:CHAR • KYG9877L1077

Current stock price

10.5501 USD
0 (0%)
Last:

This CHAR fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. CHAR Profitability Analysis

1.1 Basic Checks

  • In the past year CHAR was profitable.
CHAR Yearly Net Income VS EBIT VS OCF VS FCFCHAR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2024 0 200K -200K -400K

1.2 Ratios

Industry RankSector Rank
ROA 3.27%
ROE 3.33%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CHAR Yearly ROA, ROE, ROICCHAR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2024 0 0.2 -0.2 -0.4

1.3 Margins

  • CHAR does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CHAR Yearly Profit, Operating, Gross MarginsCHAR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2024

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. CHAR Health Analysis

2.1 Basic Checks

  • CHAR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
CHAR Yearly Shares OutstandingCHAR Yearly Shares OutstandingYearly Shares Outstanding 2024 2M 4M 6M 8M 10M
CHAR Yearly Total Debt VS Total AssetsCHAR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2024 20M 40M 60M 80M

2.2 Solvency

  • An Altman-Z score of 39.72 indicates that CHAR is not in any danger for bankruptcy at the moment.
  • There is no outstanding debt for CHAR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 39.72
ROIC/WACCN/A
WACCN/A
CHAR Yearly LT Debt VS Equity VS FCFCHAR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2024 0 20M 40M 60M 80M

2.3 Liquidity

  • A Current Ratio of 1.08 indicates that CHAR should not have too much problems paying its short term obligations.
  • CHAR has a Quick Ratio of 1.08. This is a normal value and indicates that CHAR is financially healthy and should not expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 1.08
Quick Ratio 1.08
CHAR Yearly Current Assets VS Current LiabilitesCHAR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2024 100K 200K 300K 400K

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

0

3. CHAR Growth Analysis

3.1 Past

EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocksShow best growing peers

0

4. CHAR Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 40.58, the valuation of CHAR can be described as expensive.
  • CHAR is valuated expensively when we compare the Price/Earnings ratio to 25.71, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 40.58
Fwd PE N/A
CHAR Price Earnings VS Forward Price EarningsCHAR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CHAR Per share dataCHAR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. CHAR Dividend Analysis

5.1 Amount

  • No dividends for CHAR!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

CHAR Fundamentals: All Metrics, Ratios and Statistics

CHARLTON ARIA ACQUISITI-CL A

NASDAQ:CHAR (3/12/2026, 8:00:01 PM)

10.5501

0 (0%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)11-12
Earnings (Next)N/A
Inst Owners93.51%
Inst Owner ChangeN/A
Ins Owners2.26%
Ins Owner Change0%
Market Cap115.63M
Revenue(TTM)N/A
Net Income(TTM)2.90M
AnalystsN/A
Price TargetN/A
Short Float %0.08%
Short Ratio0.31
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 40.58
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 1.33
P/tB 1.33
EV/EBITDA N/A
EPS(TTM)0.26
EY2.46%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0
BVpS7.93
TBVpS7.93
PEG (NY)N/A
PEG (5Y)N/A
Graham Number6.81
Profitability
Industry RankSector Rank
ROA 3.27%
ROE 3.33%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.08
Quick Ratio 1.08
Altman-Z 39.72
F-ScoreN/A
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A

CHARLTON ARIA ACQUISITI-CL A / CHAR Fundamental Analysis FAQ

What is the fundamental rating for CHAR stock?

ChartMill assigns a fundamental rating of 1 / 10 to CHAR.


What is the valuation status for CHAR stock?

ChartMill assigns a valuation rating of 0 / 10 to CHARLTON ARIA ACQUISITI-CL A (CHAR). This can be considered as Overvalued.


Can you provide the profitability details for CHARLTON ARIA ACQUISITI-CL A?

CHARLTON ARIA ACQUISITI-CL A (CHAR) has a profitability rating of 0 / 10.


How financially healthy is CHARLTON ARIA ACQUISITI-CL A?

The financial health rating of CHARLTON ARIA ACQUISITI-CL A (CHAR) is 5 / 10.